Methimazole (Felimazole, Felanorm) for feline hyperthyroidism — oral vs. transdermal, side effects to watch in the first 90 days, and how it fits alongside radioiodine and thyroid diet.

Methimazole is the most commonly prescribed medication for feline hyperthyroidism. It controls thyroid hormone levels — it does not cure the disease. Two FDA-approved veterinary products exist (Felimazole coated tablets and Felanorm oral solution), and in July 2025 the FDA approved the first generic methimazole coated tablets for cats. Methimazole is also available in compounded formulations including flavored liquids, chewables, and transdermal ear gels.

This article covers how methimazole works, the differences between oral and transdermal administration, what side effects to watch for during the first three months, how recheck schedules are structured, and how methimazole compares to radioiodine (I-131) and prescription thyroid diet as long-term treatment options.

Quick answer

Methimazole blocks the synthesis of thyroid hormones T4 and T3 by preventing iodine incorporation into thyroglobulin. Because hormones already in circulation remain active, it typically takes 2–4 weeks before blood work shows improvement. It is given twice daily in most cats, and dose adjustments are made in 2.5 mg increments based on total T4 results and clinical response.

Methimazole is widely used for three reasons: it is inexpensive, it is effective at controlling hormone levels, and it does not require anesthesia or specialized facilities. The tradeoff is that it is a lifelong daily medication — the thyroid nodule continues to grow, and over time the dose may need to increase or the medication may lose effectiveness.

FDA-approved products vs. compounded formulations

Product	Form	FDA status	Notes
Felimazole (Dechra)	2.5 mg, 5 mg coated tablets	FDA-approved for cats	Original veterinary-approved brand
Felanorm (Norbrook)	Oral solution	FDA-approved for cats	Liquid formulation
Methimazole Coated Tablets (Felix Pharmaceuticals)	2.5 mg, 5 mg coated tablets	FDA-approved generic (July 2025)	First generic for cats
Compounded methimazole	Transdermal gel, flavored liquid, chewable	Not FDA-approved	Compounded when cat cannot take tablets; quality varies by pharmacy

For years before Felimazole was approved, veterinarians used human-labeled methimazole (Tapazole) off-label in cats. The FDA notes that human products have not been proven safe and effective in cats and that their labels do not include cat-specific dosing or safety information. Using an FDA-approved veterinary product when available is the safer starting point.

Oral tablets vs. transdermal gel

Most cats start on oral methimazole. But pilling a cat twice a day for the rest of its life is stressful for both the owner and the cat. Transdermal methimazole — compounded into a gel applied to the hairless inner surface of the ear pinna — is the most common alternative.

Factor	Oral tablets	Transdermal gel
Onset of action	Faster; T4 normalization typically in 2–4 weeks	Slower; may take longer to achieve control
GI side effects	More common (vomiting, anorexia)	Fewer GI issues because drug bypasses the stomach
Availability	FDA-approved products available at any pharmacy	Must be compounded; quality and absorption vary
Handling safety	Wear gloves; wash hands	Must wear gloves during application and cleanup
Administration	Pill, liquid, or chewable by mouth	Apply to inner ear with gloved hand

A common clinical sequence is to start with oral methimazole, confirm that the cat tolerates it, and then switch to transdermal if pilling becomes a daily struggle. Some veterinarians start directly with transdermal for cats with a history of GI upset or in fractious cats where oral administration is unsafe.

Side effects: the first 90 days matter most

Most methimazole side effects occur during the first three months of treatment. This is why rechecks are concentrated early in the course of therapy.

Common side effects (typically mild)

Vomiting and anorexia — the most frequently reported GI signs. Giving the medication with food can help. If GI signs are persistent, transdermal gel is an alternative.
Lethargy — usually transient as the cat adjusts to the medication.
Self-excoriation — face and neck scratching, particularly around the head. This is reported in post-marketing surveillance and may require discontinuation.

Serious but less common side effects

Hematologic abnormalities — thrombocytopenia (low platelets), neutropenia (low white blood cells), and, rarely, aplastic anemia. These can be detected on routine blood work before they become clinically apparent. A cat that develops sudden bruising, bleeding, or fever needs immediate veterinary evaluation.
Hepatopathy — elevated liver enzymes and bilirubin. Jaundice, vomiting, and lethargy in a cat recently started on methimazole should prompt immediate blood work.
Facial pruritus and excoriation — reported in the Felimazole foreign market post-approval experience. Cats that begin scratching their face or neck intensely may need to discontinue methimazole.

The FDA Felimazole label notes that in a 12-week safety study, two cats collapsed and died within 12 days at a dose of 5 mg twice daily. Starting at a low dose and titrating upward based on response — rather than starting at a high dose — is the standard approach to minimize these risks.

Monitoring and recheck schedule

A typical monitoring plan looks like this:

Baseline — before starting methimazole: total T4, complete blood count (CBC), serum chemistry (including kidney values and liver enzymes), urinalysis, and blood pressure.
2–3 weeks after starting — recheck total T4 and CBC. Check for hematologic changes. Assess clinical improvement (weight, appetite, activity).
4–6 weeks — total T4, CBC, and chemistry. Dose adjustments are made based on T4. If the cat is hypothyroid (T4 below reference range), the dose is reduced — unintentional hypothyroidism accelerates kidney disease progression.
Every 3–6 months ongoing — total T4, CBC, chemistry, and urinalysis. Kidney function is monitored because hyperthyroidism can mask underlying chronic kidney disease. When thyroid hormone levels normalize, blood flow to the kidneys decreases, which can unmask renal insufficiency that was hidden by the hyperthyroid state.

This unmasking of kidney disease is not a reason to avoid treating hyperthyroidism — untreated hyperthyroidism also damages the kidneys through chronic hypertension and hyperfiltration injury. But it is a reason to monitor renal parameters closely, especially during the first few months of treatment.

Methimazole as a bridge to permanent treatment

Many veterinarians use methimazole to stabilize a cat before a permanent treatment like radioiodine (I-131) or surgery. The logic is:

Confirm that the kidneys can handle euthyroidism. Starting methimazole and rechecking kidney values after T4 normalizes gives the veterinarian a preview of what the cat's renal function will look like after permanent treatment. If azotemia develops, the veterinarian can adjust expectations and discuss whether permanent treatment is appropriate.
Discontinuation before I-131. Cats must stop methimazole at least two weeks before radioiodine treatment so that I-131 uptake by the thyroid tissue is not suppressed.

Methimazole vs. radioiodine (I-131)

Radioiodine is considered the gold standard treatment for feline hyperthyroidism. A single injection of I-131 destroys the abnormal thyroid tissue while sparing normal tissue. Cure rates exceed 90% in most referral centers. Cats stay in isolation for 5–7 days due to radiation safety regulations.

Factor	Methimazole	I-131
Goal	Control (lifelong)	Cure (one-time)
Administration	Twice-daily pill or gel	Single injection
Ongoing monitoring	Every 3–6 months	Post-treatment T4 check, then routine
Effect on thyroid nodule	None — nodule continues to grow	Destroys abnormal tissue
Cost (approximate)	$20–50/month + recheck blood work	$1,500–$3,000 one-time (varies by region)
Kidney risk assessment	Can trial first	Must assess beforehand
Anesthesia	Not required	Not required
Availability	Any veterinary clinic	Referral center with radiation license

The cost of methimazole over several years — medication plus quarterly or semiannual blood work — can approach or exceed the one-time cost of I-131. For a cat diagnosed at age 12 or 13, I-131 is often more cost-effective over the remaining lifespan. For a very old cat with significant comorbidities, methimazole may be the more pragmatic choice.

Methimazole vs. prescription thyroid diet

A prescription iodine-restricted diet (Hill's y/d) is another management option. The diet works by starving the thyroid gland of iodine, which is required for thyroid hormone synthesis. It can be effective but has strict requirements: the cat must eat only the prescription diet with no access to other food, treats, or prey. In multi-cat households, this is difficult to manage. The diet is not appropriate for cats with concurrent conditions requiring different nutritional profiles.

What owners should ask their veterinarian

What total T4 level are we targeting, and how often will we recheck it?
Should we start with oral or transdermal, and what would prompt a switch?
What blood work is scheduled for the first 2–4 weeks, and what abnormalities should prompt a call between visits?
Has kidney function been assessed at baseline, and how will we know if CKD becomes a concern once thyroid levels normalize?
Is my cat a candidate for radioiodine, and should we do a methimazole trial first to check kidney tolerance?